Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Sales/Fixed Asset

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   Sales/Fixed Asset(x) 3.312.222.212.282.12

What is the latest Sales/Fixed Asset ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Sales/Fixed Asset ratio of SYNCOM FORMULATIONS (INDIA) is 3.31 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20253.31
Mar20242.22
Mar20232.21
Mar20222.28
Mar20172.12

How is Sales/Fixed Asset of SYNCOM FORMULATIONS (INDIA) Trending?

Years Sales/Fixed Asset % Change
Mar2025 3.31
49.10
Mar2024 2.22
0.45
Mar2023 2.21
-3.07
Mar2022 2.28
7.55
Mar2017 2.12 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Sales/Fixed Asset ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,343.3 Cr 1% 3.9% -33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1%

3.9%

-33.1%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses